26.11.2012 Views

Guidelines for ATC classification and DDD assignment - WHOCC

Guidelines for ATC classification and DDD assignment - WHOCC

Guidelines for ATC classification and DDD assignment - WHOCC

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Two examples of this are as follows:<br />

- Sex hormones in certain dosage <strong>for</strong>ms or strengths are only used in the treatment<br />

of cancer <strong>and</strong> are thus classified under L02 - Endocrine therapy. Remaining<br />

dosage <strong>for</strong>ms/strengths are classified under G03 - Sex hormones <strong>and</strong> modulators<br />

of the genital system.<br />

- Clonidine is available in two different strengths. One strength, which is used<br />

mainly in the treatment of hypertension, is classified under C02 -<br />

Antihypertensives. Another strength mainly used in the treatment of migraine is<br />

classified under N02C - Antimigraine preparations.<br />

Different pharmaceutical <strong>for</strong>ms <strong>for</strong> topical <strong>and</strong> systemic use are also given separate<br />

<strong>ATC</strong> codes.<br />

Example:<br />

Prednisolone in single ingredient products is given several <strong>ATC</strong> codes due to<br />

different therapeutic use <strong>and</strong> different local application <strong>for</strong>mulations.<br />

A07EA01 Intestinal antiinflammatory agents (enemas <strong>and</strong> foams)<br />

C05AA04 Antihemorrhoidals <strong>for</strong> topical use (suppositories)<br />

D07AA03 Dermatological preparations (creams, ointments <strong>and</strong> lotions)<br />

H02AB06 Corticosteroids <strong>for</strong> systemic use (tablets, injections)<br />

R01AD02 Nasal decongestants (nasal sprays/drops)<br />

S01BA04 Ophthalmologicals (eye drops)<br />

S02BA03 Otologicals (ear drops)<br />

A medicinal product may be used <strong>for</strong> two or more equally important indications,<br />

<strong>and</strong> the main therapeutic use of a drug may differ from one country to another.<br />

This will often give several <strong>classification</strong> alternatives. Such drugs are usually only<br />

given one code, the main indication being decided on the basis of the available<br />

literature. Problems are discussed in the WHO International Working Group <strong>for</strong><br />

Drug Statistics Methodology where the final <strong>classification</strong> is decided. Crossreferences<br />

will be given in the guidelines to indicate the various uses of such drugs.<br />

The <strong>ATC</strong> system is not strictly a therapeutic <strong>classification</strong> system. At all <strong>ATC</strong><br />

levels, <strong>ATC</strong> codes can be assigned according to the pharmacology of the product.<br />

Subdivision on the mechanism of action will, however, often be rather broad, since<br />

a too detailed <strong>classification</strong> according to mode of action often will result in having<br />

one substance per subgroup which as far as possible is avoided (e.g.<br />

antidepressants). Some <strong>ATC</strong> groups are subdivided in both chemical <strong>and</strong><br />

pharmacological groups (e.g. <strong>ATC</strong> group J05A - Direct acting antivirals).<br />

17

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!